Quantcast
Last updated on April 16, 2014 at 14:11 EDT

Latest Thomas M. Riedhammer Stories

2013-05-02 08:36:23

NEW YORK, May 2, 2013 /PRNewswire/ -- Ohr Pharmaceutical Inc. (OTCQB: OHRP), a pharmaceutical company focused on the development of novel therapeutics for unmet medical needs, today announced the appointment of Thomas M. Riedhammer, Ph.D., to its Board of Directors. Dr. Riedhammer has over 35 years of ophthalmic industry experience, working for large and small pharmaceutical companies engaged in drug development through commercialization. "We are pleased to have brought on someone of Dr....